1. Clinical outcomes of roux-en-Y gastric bypass versus medical therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
- Author
-
Gul, Dua, Khan, Aimen Waqar, Butt, Muhammad Abdurrahman, Suheb, Mahammed Khan, Sartaj, Sahil, Chabria, Sohanjeet, Bint-e-Hina, Rimsha, Shaukat, Maryam, Ali, Zeeshan, Bhurchandi, Shirirang Kishor, Syed, Abdul Ahad, Khatri, Mahima, and Kumar, Satesh
- Subjects
TYPE 2 diabetes ,GASTRIC bypass ,MEDICAL sciences ,DISEASE remission ,RANDOMIZED controlled trials - Abstract
Background: The growing incidence of obesity has led to a proportionate rise in type 2 diabetes mellitus (T2DM) and its associated complications. We aimed to compare the long-term outcomes of Roux-en-y Gastric Bypass surgery (RYGB) and conventional medical management in T2DM obese patients. Methods: PubMed, Google Scholar, and Clinicaltrial.gov were searched from inception to September 2023. Randomized Controlled Trials (RCTs) and cohort studies were included in this meta-analysis. The primary outcomes were the T2DM remission at 1, 2, 3, and 5 years and the accomplishment of the ADA composite triple treatment goal. The revised Cochrane risk of bias tool 2.0 and New-Castle Ottawa scale were used to assess the quality of the studies. This meta-analysis was registered prospectively on PROSPERO CRD42023466324. Results: Of the 3,323 studies yielded from our initial search, 22 were included in this evidence analysis, with 5,176 total patients (1,984 and 3,192 patients in RYGB and conventional medical management groups). A significant increase in the accomplishment in the ADA's composite triple treatment goal was observed in RYGB group as compared to the conventional medical management group (RR 2.41, 95% CI 1.39–4.15, p-value 0.002, I
2 35%). Diabetes remission was a clinically successful outcome after 1, 2, 3, and 5 years of the RYGB surgery in the patients (1 year; RR 4.74, 95%CI 2.46–9.12, p-value < 0.00001, I2 0%, 2 years; RR 8.95, 95% CI 1.71–46.71, p-value 0.009, I2 92%3 years; RR 18.18 95%CI 7.57–43.62, p-value < 0.00001, I2 0%, 5 years; RR 0.22, 95% CI 2.31–16.75, p-value 0.0003, I2 = 71%). Conclusion: The pooled analysis of the given data concluded that the RYGB surgery was more effective in treating T2DM in patients than conventional medical management. [ABSTRACT FROM AUTHOR]- Published
- 2025
- Full Text
- View/download PDF